Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H8N4O3 |
| Molecular Weight | 232.1955 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NN=C(\C=C\C2=CC=C(O2)[N+]([O-])=O)C=C1
InChI
InChIKey=XDWLRMBWIWKFNC-HNQUOIGGSA-N
InChI=1S/C10H8N4O3/c11-9-5-2-7(12-13-9)1-3-8-4-6-10(17-8)14(15)16/h1-6H,(H2,11,13)/b3-1+
| Molecular Formula | C10H8N4O3 |
| Molecular Weight | 232.1955 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
The nitrofuran derivative, nifurprazine, is a topical antibacterial agent used mainly for the treatment of animal diseases. It is a trypanocidal drug. Nifurprazine proved to be the most promising derivative since it was redox-cycled by both T. cruzi LipDH and TR and had pronounced antiparasitic effects in cultures of T. cruzi and Trypanosoma brucei.
Approval Year
Sample Use Guides
At concentrations of 100 uM, nifurprazine caused a 72% inhibition of trypanothione reductase (TR) activity. At 10 uM, nifurprazine inhibited parasite growth completely, but was also toxic to the mammalian host cells. Nifurprazine (3 uM) induced a 100% growth inhibition of T. brucei.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:12:11 GMT 2023
by
admin
on
Fri Dec 15 16:12:11 GMT 2023
|
| Record UNII |
72ZUT1JIEB
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C28394
Created by
admin on Fri Dec 15 16:12:11 GMT 2023 , Edited by admin on Fri Dec 15 16:12:11 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
6436113
Created by
admin on Fri Dec 15 16:12:11 GMT 2023 , Edited by admin on Fri Dec 15 16:12:11 GMT 2023
|
PRIMARY | |||
|
216-563-2
Created by
admin on Fri Dec 15 16:12:11 GMT 2023 , Edited by admin on Fri Dec 15 16:12:11 GMT 2023
|
PRIMARY | |||
|
1614-20-6
Created by
admin on Fri Dec 15 16:12:11 GMT 2023 , Edited by admin on Fri Dec 15 16:12:11 GMT 2023
|
PRIMARY | |||
|
SUB09275MIG
Created by
admin on Fri Dec 15 16:12:11 GMT 2023 , Edited by admin on Fri Dec 15 16:12:11 GMT 2023
|
PRIMARY | |||
|
2062
Created by
admin on Fri Dec 15 16:12:11 GMT 2023 , Edited by admin on Fri Dec 15 16:12:11 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105219
Created by
admin on Fri Dec 15 16:12:11 GMT 2023 , Edited by admin on Fri Dec 15 16:12:11 GMT 2023
|
PRIMARY | |||
|
72ZUT1JIEB
Created by
admin on Fri Dec 15 16:12:11 GMT 2023 , Edited by admin on Fri Dec 15 16:12:11 GMT 2023
|
PRIMARY | |||
|
m846
Created by
admin on Fri Dec 15 16:12:11 GMT 2023 , Edited by admin on Fri Dec 15 16:12:11 GMT 2023
|
PRIMARY | Merck Index | ||
|
3796
Created by
admin on Fri Dec 15 16:12:11 GMT 2023 , Edited by admin on Fri Dec 15 16:12:11 GMT 2023
|
PRIMARY | |||
|
100000083895
Created by
admin on Fri Dec 15 16:12:11 GMT 2023 , Edited by admin on Fri Dec 15 16:12:11 GMT 2023
|
PRIMARY | |||
|
DTXSID40167141
Created by
admin on Fri Dec 15 16:12:11 GMT 2023 , Edited by admin on Fri Dec 15 16:12:11 GMT 2023
|
PRIMARY | |||
|
C90984
Created by
admin on Fri Dec 15 16:12:11 GMT 2023 , Edited by admin on Fri Dec 15 16:12:11 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
